How to Choose an NMN Supplement: What to Look For

Our knowledge-base entry on NMN explains that human evidence for this compound is still early, and that market popularity has clearly outpaced the pace of large clinical trials. What that entry doesn't cover is a separate, equally important problem: even if someone knowingly decides to experiment with NMN at this stage of the evidence, it's an entirely different question whether the bottle they're actually holding contains what the label promises — and whether they can even legally buy it in Poland.

That's not a rhetorical question. Independent lab testing of commercially available NMN products, covered in the next section, has found discrepancies between declared and actual content reaching as much as 100 percentage points — meaning, literally, a bottle with zero active ingredient sold as a fully-fledged NMN supplement.

In other words: in this specific test, roughly one in six products on the market contained zero of the substance the customer was paying for, and only two of eighteen exceeded their label claim — the rest fell short to varying degrees. This isn't an isolated result; other independent tests of commercial NMN and NR products reported in industry media described a similar pattern — a significant share of tested products below 80% of their claim, and some with zero detectable active ingredient.

Even a product that genuinely contained the declared amount of NMN at the time of manufacture can lose a significant share of that content before it reaches the consumer's mouth, because of the molecule's chemical instability. Studies of NMN degradation kinetics in aqueous solution show that it breaks down into nicotinamide (ordinary vitamin B3) via a first-order reaction, and the rate of this breakdown is strongly dependent on temperature and pH.

In practice, this means storage conditions matter for real, not just as a formality on the leaflet: NMN left in a hot car in summer, in direct sunlight, or in a humid room can lose a meaningful share of its active content before the expiration date printed on the package. This is an additional reason, independent of manufacturer honesty, why a label claim accurate at the time of production doesn't guarantee the same content on the day the consumer actually takes the capsule.

This may be the least-known, most practically relevant problem for a reader in Poland: NMN is not currently authorized for legal sale as a food or food supplement within the European Union, including Poland, because it formally remains under review as a so-called novel food under EU regulation. Until that procedure ends with a positive implementing decision from the European Commission, placing NMN on the EU market as a food ingredient or supplement isn't compliant with the law — regardless of how widely it's sold online today.

In 2025 the European Food Safety Authority (EFSA) began a formal safety assessment of β-NMN as a novel food at the request of the company EffePharm, and in May 2026 issued a positive scientific opinion, proposing a safe daily intake of 300 mg for the general population (excluding pregnant and breastfeeding women). That's still only one stage of a long procedure, though — a positive EFSA scientific opinion is not yet equivalent to formal authorization: actually allowing NMN onto the EU market still requires an implementing act from the European Commission adding it to the EU list of novel foods, and no such act has been issued yet.

The practical takeaway from both situations — in the EU and in the US — is similar: NMN's wide availability in online sales is not the same thing as a clearly settled legal status. Buyers should be aware of this, rather than assuming that a product's mere presence on the market proves it fully complies with applicable food law.

As our knowledge-base entry explains, NMN remains a compound at an early stage of human evidence — but even someone who knowingly accepts that uncertainty should be aware of two additional problems, entirely independent of the underlying biology: the real risk of buying a product that doesn't contain its declared amount of active ingredient, and NMN's still-unresolved legal status as a novel food in the European Union. Neither of these is a reason for panic, but both are reasons to approach the purchase of a specific product with more caution than its sheer availability online would suggest.